Response assessment of somatostatin receptor targeted radioligand therapies for progressive intracranial meningioma

被引：10
|
作者：
Muether, Michael [1 ]
Roll, Wolfgang [2 ]
Brokinkel, Benjamin [1 ]
Zinnhardt, Bastian [3 ]
Sporns, Peter B. [4 ]
Seifert, Robert [2 ]
Schafers, Michael [3 ]
Weckesser, Matthias [2 ]
Stegger, Lars [2 ]
Stummer, Walter [1 ]
Rahbar, Kambiz [2 ]
机构：
[1] Univ Hosp Munster, Dept Neurosurg, Munster, Germany
[2] Univ Hosp Munster, Dept Nucl Med, Munster, Germany
[3] WWU, European Inst Mol Imaging, Munster, Germany
[4] Univ Hosp Munster, Inst Clin Radiol, Munster, Germany
来源：
NUKLEARMEDIZIN-NUCLEAR MEDICINE | 2020年 / 59卷 / 05期
关键词：
Lu-177-DOTATATE; PRRT; meningioma; RADIONUCLIDE THERAPY; PET; Y-90-DOTATOC; GUIDELINES; RECURRENT; EANM;
D O I：
10.1055/a-1200-0989
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Zusammenfassung
引用
收藏
页码：348 / 355
页数：8
相关论文
共 50 条
  • [1] Response assessment of radioligand therapies
    Lopci, Egesta
    Prasad, Vikas
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [2] Somatostatin Receptor-Targeted Radiopeptide Therapy in Patients with Progressive Unresectable Meningioma REPLY
    Radojewski, Piotr
    Dumont, Rebecca A.
    Marincek, Nicolas
    Brunner, Philippe
    Mueller-Brand, Jan
    Maecke, Helmut R.
    Briel, Matthias
    Walter, Martin A.
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (10) : 1657 - 1658
  • [3] Somatostatin Receptor targeted radioligand therapy in head and neck paraganglioma
    Roll, W.
    Muether, M.
    Zinnhardt, B.
    Stegger, L.
    Weckesser, M.
    Schaefers, M.
    Stummer, W.
    Rahbar, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S637 - S637
  • [4] SOMATOSTATIN RECEPTOR TARGETED RADIOLIGAND THERAPYIN HEAD AND NECK PARAGANGLIOMA
    Muether, M.
    Roll, W.
    Stegger, L.
    Zinnhardt, B.
    Schafers, M.
    Weckesser, M.
    Rahbar, K.
    Stummer, W.
    NEURO-ONCOLOGY, 2019, 21 : 83 - 83
  • [5] Somatostatin Receptor-Targeted Radioligand Therapy in Head and Neck Paraganglioma
    Roll, Wolfgang
    Muther, Michael
    Sporns, Peter B.
    Zinnhardt, Bastian
    Molina, Eric Suero
    Seifert, Robert
    Schafers, Michael
    Weckesser, Matthias
    Stegger, Lars
    Beule, Achim G.
    Stummer, Walter
    Rahbar, Kambiz
    WORLD NEUROSURGERY, 2020, 143 : E391 - E399
  • [6] Somatostatin-receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE/-TOC uptake
    Seystahl, Katharina
    Stoecklein, Veit
    Schuller, Ulrich
    Rushing, Elisabeth
    Nicolas, Guillaume
    Schafer, Niklaus
    Ilhan, Harun
    Pangalu, Athina
    Weller, Michael
    Tonn, Jorg-Christian
    Sommerauer, Michael
    Albert, Nathalie L.
    NEURO-ONCOLOGY, 2016, 18 (11) : 1538 - 1547
  • [7] Differentiation of intracranial meningioma from dural metastasis with somatostatin receptor scintigraphy: An underutilised solution to a common problem
    Liddy, S.
    Duignan, J.
    Haughey, A.
    Crown, J.
    McNeill, G.
    Killeen, R. P.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2020, 113 (06) : 425 - 426
  • [8] 177 Lu-labeled somatostatin receptor targeted radionuclide therapy dosimetry in meningioma: a systematic review
    Boursier, Caroline
    Zaragori, Timothee
    Imbert, Laetitia
    Verger, Antoine
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 68 (03): : 217 - 225
  • [9] Assessment of radiologic response to targeted therapies in patients with hepatocellular carcinoma
    Sacco, Rodolfo
    FUTURE ONCOLOGY, 2014, 10 (13) : 2073 - 2079
  • [10] The Clinical Utility of Receptor Metabolic Response Evaluation Based on Somatostatin Receptor Imaging (SRI), in Patients with Advanced, Non-resectable, Progressive GEP-NET after Combine Radioligand and CAPTEM therapy
    Cwikla, J.
    Zrajkowska, A.
    Nowicki, M.
    Palucki, J. M.
    Kempinska-Wrobel, M.
    Kolasinska-Cwikla, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S666 - S666
12345